Previously, based on invasive breast carcinomas of all intrinsic subtypes, we have reported 8.4-fold increased risk of mortality associated with the combination of separase, securin and cdk1, each a crucial regulator of cell cycle-progression [76]. This evidence concerns the gene ESPL1 and invasive breast carcinoma.